These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15928311)

  • 1. Abnormal parathyroid cell proliferation precedes biochemical abnormalities in a mouse model of primary hyperparathyroidism.
    Mallya SM; Gallagher JJ; Wild YK; Kifor O; Costa-Guda J; Saucier K; Brown EM; Arnold A
    Mol Endocrinol; 2005 Oct; 19(10):2603-9. PubMed ID: 15928311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
    Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
    Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.
    Imanishi Y; Hosokawa Y; Yoshimoto K; Schipani E; Mallya S; Papanikolaou A; Kifor O; Tokura T; Sablosky M; Ledgard F; Gronowicz G; Wang TC; Schmidt EV; Hall C; Brown EM; Bronson R; Arnold A
    J Clin Invest; 2001 May; 107(9):1093-102. PubMed ID: 11342573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
    Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice.
    Cheng Z; Liang N; Chen TH; Li A; Santa Maria C; You M; Ho H; Song F; Bikle D; Tu C; Shoback D; Chang W
    J Bone Miner Res; 2013 May; 28(5):1087-100. PubMed ID: 23239173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of hyperparathyroidism and potential targets for drug development.
    Krebs LJ; Arnold A
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):167-79. PubMed ID: 12476790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
    Imanishi Y; Kawata T; Kenko T; Wada M; Nagano N; Miki T; Arnold A; Inaba M
    Calcif Tissue Int; 2011 Jul; 89(1):29-35. PubMed ID: 21541686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcimimetics and hyperparathyroidism.
    Krebs LJ
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1080-5. PubMed ID: 15535429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.
    Nakajima K; Umino K; Azuma Y; Kosaka S; Takano K; Obara T; Sato K
    J Bone Miner Metab; 2009; 27(2):224-33. PubMed ID: 19194773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid-Targeted Overexpression of Regulator of G-Protein Signaling 5 (RGS5) Causes Hyperparathyroidism in Transgenic Mice.
    Balenga N; Koh J; Azimzadeh P; Hogue J; Gabr M; Stains JP; Olson JA
    J Bone Miner Res; 2019 May; 34(5):955-963. PubMed ID: 30690792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism.
    Wallfelt C; Gylfe E; Larsson R; Ljunghall S; Rastad J; Akerström G
    J Endocrinol; 1988 Mar; 116(3):457-64. PubMed ID: 3351432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-mediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet.
    de Francisco AL; Izquierdo M; Cunningham J; Piñera C; Palomar R; Fresnedo GF; Amado JA; Unzueta MG; Arias M
    Nephrol Dial Transplant; 2008 Sep; 23(9):2895-901. PubMed ID: 18424820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etelcalcetide decreases the PTH-calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidism.
    Hayashi N; Imanishi Y; Hirakawa T; Kobayashi I; Tateishi T; Miyaoka D; Nagata Y; Mori K; Morioka T; Inoue A; Harada K; Inaba M; Emoto M
    J Bone Miner Metab; 2021 May; 39(3):430-438. PubMed ID: 33196900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
    Bas S; Aguilera-Tejero E; Bas A; Estepa JC; Lopez I; Madueño JA; Rodriguez M
    J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.
    Juhlin C; Klareskog L; Nygren P; Ljunghall S; Gylfe E; Rastad J; Akerström G
    Endocrinology; 1988 Jun; 122(6):2999-3001. PubMed ID: 2836180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
    Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H
    J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optogenetic approach for regulating human parathyroid hormone secretion.
    Liu Y; Zhang L; Hu N; Shao J; Yang D; Ruan C; Huang S; Wang L; Lu WW; Zhang X; Yang F
    Nat Commun; 2022 Feb; 13(1):771. PubMed ID: 35140213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTH hypersecretion triggered by a GABA
    Chang W; Tu CL; Jean-Alphonse FG; Herberger A; Cheng Z; Hwong J; Ho H; Li A; Wang D; Liu H; White AD; Suh I; Shen W; Duh QY; Khanafshar E; Shoback DM; Xiao K; Vilardaga JP
    Nat Metab; 2020 Mar; 2(3):243-255. PubMed ID: 32694772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.